Abstract
Many immunosuppressive drugs to show either experimental or clinical effects on glucose metabolism and regulation. These can arise from either a direct toxic effect on islet beta cells, or an indirect effect, such as insulin resistance. The problem of immunosuppression-induced diabetes is clinically relevant because patients may develop long-term degenerative complications related to glucose intolerance or suffer a deterioration of their quality of life resulting from a need for insulin injections and strict diet, an unexpected restriction in a transplanted patient with a functional organ. Disorders of glucose metabolism may also enhance complications induced by some other metabolic abnormalities found in transplant recipients, such as atherosclerosis and disorders in lipid metabolism. The diabetic state can decompensate or accelerate cardiovascular complications, which is a leading cause of patient death after transplantation.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Flanagan WH, Corthesy B, Bram RJ, Crabtree GR. Nuclear association of a T cell transcription factor blocked by FK 506 and cyclosporin A. Nature. 1991; 352: 803–807.
Isoniemi H. Renal Allograft Immunosuppression. Glucose intolerance occurring in different immunosuppressive treatments. Clin. Transplant. 1991; 5: 268–272.
Krentz AJ, Dousset B, Mayer D et al. Metabolic effects of cyclosporin and FK 506 in liver transplant recipients. Diabetes. 1993; 42: 1753–1759.
Jindal RM, Popescu I, Schwart ME, Emre S, Boccagni P, Miller CM. Diabetogenicity of FK versus cyclosporine in liver transplant recipients. Transplantation. 1994; 58: 370–372.
Pirsh JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression after cadaveric renal transplantation FK 506 Kidney Transplant Study Group. Transplantation. 1997; 63: 977–983.
Mayer AD, Dmitrewski J, Squifflet JP et al. Multicenter randomized trial comparing tacrolimus (FK 506) and cyclosporine in the prevention of renal allograft rejection: A report of the European Tacrolimus Multicenter Renal Study Group. Transplantation. 1997; 64: 436–443.
Sutherland D, Gruessner Gores P. Pancreas and islet cell transplantation. Transplant. Immunol. 1995; 147–160.
Fabrega AJ, Cohan J, Meslar P, Pollak R. Effect of steroid withdrawal on long term renal allograft recipients with post transplantation diabetes. Surgery. 1994; 116: 792–797.
Hollander AA, Hene RJ, Herman J, Van Der Houde FJ. Late prednisone withdrawal in kidney transplanted patients. A randomized study. J. Am Soc. Nephrol. 1997; 8: 294–301.
Ratcliffe PJ, Dudley CR, Higgins RM, Firth JD, Morris PJ. Randomized controlled trial of steroid withdrawal in renal transplant patients receiving triple immunosuppression. Lancet. 1996; 348: 643–648.
Stegall MD, Wachs ME, Everson G, Steinberg T, Bilir B, Shrestha R, Karrer F, Kam I. Predisone withdrawal 14 days after liver transplantation with Mycophenolate. Transplantation. 1997; 64: 1755–1760.
Shapiro R, Scantlabury VP, Jordan ML, Starzl 1 E. Reversibility of tacrolimus induced posttransplant diabetes: an illustrative case and review of the literature. Transplant. Proc. 1997; 29: 2737–2738.
Zanker B, Schneebeeberger H, Rothenpieler U et al. Mucophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression. Transplantation. 1998; 66: 44–49.
Editor information
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Martin, X. (1999). Diabetogenic effect of immunosuppressive drugs. In: Cochat, P., Traeger, J., Merieux, C., Derchavane, M. (eds) Immunosuppression under Trial. Transplantation and Clinical Immunology, vol 31. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4643-2_12
Download citation
DOI: https://doi.org/10.1007/978-94-011-4643-2_12
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5960-2
Online ISBN: 978-94-011-4643-2
eBook Packages: Springer Book Archive